First Report of Proton Beam Therapy in a Patient With a Left Ventricular Assist Device.


Journal

ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109

Informations de publication

Date de publication:
01 05 2022
Historique:
entrez: 3 5 2022
pubmed: 4 5 2022
medline: 6 5 2022
Statut: ppublish

Résumé

A 77 year old man previously implanted with a HeartMate II left ventricular assist device (LVAD) as destination therapy and an implantable cardioverter defibrillator presented with a left upper lobe squamous cell lung cancer. Oncology determined that proton beam therapy was indicated for treatment, and a multidisciplinary team of radiation physicists, radiation oncologists, and LVAD providers developed a protocol to proceed safely. He was successfully treated with combined proton beam radiation therapy and reduced dose chemotherapy. This case demonstrates feasibility and considerations of proton beam therapy for malignancy relevant to patients with implantable cardiac devices including LVADs.

Identifiants

pubmed: 35503645
doi: 10.1097/MAT.0000000000001478
pii: 00002480-202205000-00024
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e84-e86

Informations de copyright

Copyright © ASAIO 2021.

Déclaration de conflit d'intérêts

Disclosure: The authors have no conflicts of interest to report.

Références

Hanff TC, Birati EY: Left ventricular assist device as destination therapy: A state of the science and art of long-term mechanical circulatory support. Curr Heart Fail Rep 16: 168–179, 2019.
Ostertag-Hill CA, Mudd J, Werle DP, Tieu BH, Nabavizadeh N: Safe delivery of lung stereotactic body radiation therapy in a patient with a left ventricular assist device and implantable cardioverter defibrillator. Clin Case Rep 6: 1704–1707, 2018.
Emerson LY, Deek MP, Almendral J, Jabbour SK: Radiation therapy in patients with left ventricular assist device: A case report and literature review. Pract Radiat Oncol 6: e145–e147, 2016.
Baumann BC, Mitra N, Harton JG, et al.: Comparative effectiveness of proton vs photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer. JAMA Oncol 6: 237–246, 2020.
Ramella S, D’Angelillo RM: Proton beam or photon beam radiotherapy in the treatment of non-small-cell lung cancer. Lancet Oncol 21: 873–875, 2020.
Oshiro Y, Sugahara S, Noma M, et al.: Proton beam therapy interference with implanted cardiac pacemakers. Int J Radiat Oncol Biol Phys 72: 723–727, 2008.
Miften M, Mihailidis D, Kry SF, et al.: Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: A report of the AAPM TG-203†. Med Phys 46: e757–e788, 2019.
Gossman MS, Graham JD, Das IJ, et al.: Evaluation of a ventricular assist device system: Stability in a proton beam therapy. ASAIO J 58: 597–600, 2012.
Chelikani NM, Masterson K, Down LA, et al.: Effects of gamma radiation on a ventricular assist device and its percutaneous lead components. ASAIO J 58: 19–24, 2012.

Auteurs

Erin M Schumer (EM)

From the Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.

Sarah Schettle (S)

From the Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.

John M Stulak (JM)

From the Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.

Andrew N Rosenbaum (AN)

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH